Parkinson’s Disease

Latest News

Parkinson Disease: The Breakdown and Pathophysiology of Chronic Pain

By

Tori Rodriguez

Tori Rodriguez, MA, LPC, discusses chronic pain among patients with Parkinson disease and the breakdown of disease subtypes, classification, and pathophysiology.

Risk of Suicide Twice as High for People With Parkinson Disease

By

Heather R. Johnson

While comorbidities with mental disorders are common in those with Parkinson Disease (PD), it is unclear whether PD is associated with an increased risk of suicide.

Telehealth Use Up Markedly Among Parkinson Patients

Parkinson disease symptoms and management practices were markedly affected by COVID-19.

Schizophrenia Tied to Increased Risk for Later Parkinson Disease

Authors say risk may be due to alterations in the brain’s dopamine system

MIND and Mediterranean Diets Tied to Delayed Parkinson Onset

There is a strong correlation between the age of onset of Parkinson disease (PD) and dietary habits.

Nilotinib Ineffective for the Treatment of Advanced Parkinson Disease

By

Jessica Nye, PhD

The objective of this study was to access safety and tolerability of nilotinib in participants with moderately advanced Parkinson Disease.

Vitamins E, C Inversely Linked to Risk for Parkinson Disease

Dietary vitamin E and vitamin C intake may be inversely associated with Parkinson disease risk.

Suicide Risk Higher Among Patients With Parkinson Disease

Parkinson disease is associated with an increased risk for suicide versus population-based controls.

Therapies Which Enhance PLCG2 Activity May Be Effective in Treating Parkinson and Alzheimer Diseases

By

Jessica Nye, PhD

The study authors sought to determine which components of the peripheral immune response correlated with diagnoses of Alzheimer or Parkinson Disease.

Researchers Explore Gene Regulatory Pathways and Neurological Disease

By

Mary Stroka

Study results provide new insight into how neuron subtypes outside the substantia nigra pars compacta may be compensating at a molecular level for differences in the motor production neural circuit during the progression of Parkinson’s disease.